|
| 30011094 | Michael Kleerekoper (August 18, 1944 to May 10, 2018): In Relentless Pursuit of a Better Way. | Journal of Bone and Mineral Research | 2018 |
| 27643923 | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY. | Endocrine Practice | 2016 |
| 27662240 | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016. | Endocrine Practice | 2016 |
| 24897747 | Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength. | Journal of Bone and Joint Surgery | 2014 |
| 21334222 | Poststroke fractures in a bi-ethnic community. | Journal of Stroke and Cerebrovascular Diseases | 2012 |
| 22523717 | Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration. | Journal of Osteoporosis | 2012 |
| 22407970 | Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture. | Journal of Bone and Mineral Research | 2012 |
| 21502313 | Clinical applications for vitamin D assays: what is known and what is wished for. | Clinical Chemistry | 2011 |
| 20969721 | Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition. | Aging Cell | 2011 |
| 20051275 | Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. | | 2010 |
| 30764040 | New and improved FRAX for predicting fragility fractures: a work in progress. | | 2010 |
| 21216723 | American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. | Endocrine Practice | 2010 |
| 21224201 | American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. | Endocrine Practice | 2010 |
| 20566620 | Postmenopausal hormone therapy: an Endocrine Society scientific statement. | J Clin Endocrinol Metab | 2010 |
| 19832775 | An unsatisfactory report card. | Acta Neurologica Scandinavica | 2009 |
| 18322050 | Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. | Clinical journal of the American Society of Nephrology : CJASN | 2008 |
| 19092320 | Fat embolism syndrome. | American Journal of the Medical Sciences | 2008 |
| 18057878 | Risk of fractures after stroke. | Cerebrovascular Diseases | 2008 |
| 18677150 | Osteoporosis prevention and management: an evidence-based review. | Clinical Obstetrics and Gynecology | 2008 |
| 18277912 | Soy isoflavones in the management of postmenopausal osteoporosis. | Menopause | 2008 |
| 18001325 | Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes. | Journal of Neuroendocrinology | 2007 |
| 30743750 | Postmenopausal osteoporosis: an update on current and future therapeutic options. | | 2007 |
| 17982350 | Glucocorticoid-induced osteoporosis. | Current Opinion in Endocrinology, Diabetes and Obesity | 2007 |
| 16772207 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. | Endocrine Practice | 2006 |
| 16912661 | Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-sectional exploratory study in healthy volunteers. | Menopause | 2006 |
| 16909196 | Osteoporosis prevention and therapy: preserving and building strength through bone quality. | Osteoporosis International | 2006 |
| 16901802 | Secondary osteoporosis: a review of the recent evidence. | Endocrine Practice | 2006 |
| 16932308 | How common are functional incidentalomas of the parathyroid gland? | | 2006 |
| 16214438 | Usefulness of bone mineral density to predict significant coronary artery disease. | American Journal of Cardiology | 2005 |
| 15654581 | Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women. | Osteoporosis International | 2005 |
| 15852199 | Prevention of postmenopausal bone loss and treatment of osteoporosis. | Seminars in Reproductive Medicine | 2005 |
| 16264406 | Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line. | Neuroendocrinology Letters | 2005 |
| 16306093 | Monitoring osteoporosis therapy. | Clinical Chemistry | 2005 |
| 16334412 | Is BMD testing appropriate for all menopausal women? | International Journal of Fertility and Women's Medicine | 2005 |
| 15166867 | Treatment of osteoporosis. | Clinical Obstetrics and Gynecology | 2004 |
| 15337608 | Neurologic disease, falls and fractures. | Journal of the Neurological Sciences | 2004 |
| 15589499 | The further evolution of hyperparathyroidism: Implications for clinical care. | American Journal of Medicine | 2004 |
| 15249762 | Body composition profiles derived from dual-energy X-ray absorptiometry, total body scan, and mortality. | Prev Cardiol | 2004 |
| 14715483 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. | Endocrine Practice | 2003 |
| 15981950 | Prevention and treatment of postmenopausal osteoporosis. | Treatments in Endocrinology | 2003 |
| 12466320 | Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. | Journal of Clinical Endocrinology and Metabolism | 2002 |
| 12510447 | Routine bone densitometry in elderly men? | Postgraduate Medicine | 2002 |
| 12020302 | Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. | JAMA - Journal of the American Medical Association | 2002 |
| 12425697 | A woman attempting to discontinue hormone therapy. | JAMA - Journal of the American Medical Association | 2002 |
| 11805003 | Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. | Clinical Chemistry | 2002 |
| 12195531 | Lessons from the skeleton: was the Women's Health Initiative (WHI) a primary prevention trial? | Osteoporosis International | 2002 |
| 12412771 | Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. | Journal of Bone and Mineral Research | 2002 |
| 11269564 | Comparative safety of bone remodeling agents with a focus on osteoporosis therapies. | Journal of Clinical Pharmacology | 2001 |
| 11477303 | Importance of precision in bone density measurements. | Journal of Clinical Densitometry | 2001 |
| 11468220 | Biochemical markers of bone turnover: why theory, research, and clinical practice are still in conflict. | Clinical Chemistry | 2001 |